Connecticut 2017 Regular Session

Connecticut Senate Bill SB00021 Compare Versions

Version 1 (Old)

Version 2 (New)

Old	New		Differences
1	1		General Assembly Committee Bill No. 21
2	2		January Session, 2017 LCO No. 4432
3		-	~~_____SB00021INSAPP030817____~~
	3	+	04432SB00021INS
4	4		Referred to Committee on INSURANCE AND REAL ESTATE
5	5		Introduced by:
6	6		(INS)
7	7
8	8		General Assembly
9	9
10	10		Committee Bill No. 21
11	11
12	12		January Session, 2017
13	13
14	14		LCO No. 4432
15	15
16		-	~~_____SB00021INSAPP030817____~~
	16	+	04432SB00021INS
17	17
18	18		Referred to Committee on INSURANCE AND REAL ESTATE
19	19
20	20		Introduced by:
21	21
22	22		(INS)
23	23
24	24		AN ACT CONCERNING HEALTH INSURANCE COVERAGE OF ORALLY AND INTRAVENOUSLY ADMINISTERED MEDICATIONS.
25	25
26	26		Be it enacted by the Senate and House of Representatives in General Assembly convened:
27	27
28	28		Section 1. (NEW) (Effective January 1, 2018) Each insurance company, hospital service corporation, medical service corporation, health care center, fraternal benefit society or other entity that delivers, issues for delivery, renews, amends or continues in this state an individual health insurance policy providing coverage of the type specified in subdivision (1), (2), (4), (11), (12) or (16) of section 38a-469 of the general statutes that provides coverage for prescription drugs shall provide coverage for intravenously administered prescription drugs on a basis no less favorable than orally administered prescription drugs.
29	29
30	30		Sec. 2. (NEW) (Effective January 1, 2018) Each insurance company, hospital service corporation, medical service corporation, health care center, fraternal benefit society or other entity that delivers, issues for delivery, renews, amends or continues in this state a group health insurance policy providing coverage of the type specified in subdivision (1), (2), (4), (11), (12) or (16) of section 38a-469 of the general statutes that provides coverage for prescription drugs shall provide coverage for intravenously administered prescription drugs on a basis no less favorable than orally administered prescription drugs.
31	31
32	32
33	33
34	34
35	35		This act shall take effect as follows and shall amend the following sections:
36	36		Section 1 January 1, 2018 New section
37	37		Sec. 2 January 1, 2018 New section
38	38
39	39		This act shall take effect as follows and shall amend the following sections:
40	40
41	41		Section 1
42	42
43	43		January 1, 2018
44	44
45	45		New section
46	46
47	47		Sec. 2
48	48
49	49		January 1, 2018
50	50
51	51		New section
52	52
	53	+	Statement of Purpose:
	54	+
	55	+	To require health insurance policies that provide coverage for prescription drugs to provide coverage for intravenously administered drugs on a basis no less favorable than orally administered drugs.
	56	+
	57	+	[Proposed deletions are enclosed in brackets. Proposed additions are indicated by underline, except that when the entire text of a bill or resolution or a section of a bill or resolution is new, it is not underlined.]
53	58
54	59
55		-	INS Joint Favorable C/R APP
56	60
57		-	~~INS~~
	61	+	Co-Sponsors: SEN. LOONEY, 11th Dist.
58	62
59		-	~~Joint Favorable C/R~~
	63	+	Co-Sponsors:
60	64
61		-	APP
	65	+	SEN. LOONEY, 11th Dist.
	66	+
	67	+	S.B. 21